Hospital Readmissions Among Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Arformoterol or Fluticasone/Salmeterol

被引：0
|
作者：
Stensland, Mike [1 ]
Bollu, Vamsi [1 ]
Donohue, James [1 ]
机构：
[1] Agile Outcomes Res Inc, Rochester, MN USA
来源：
CHEST | 2015年 / 148卷 / 04期
关键词：
D O I：
10.1378/chest.2278614
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
716A
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
    Wedzicha, Jadwiga A.
    Calverley, Peter M. A.
    Seemungal, Terence A.
    Hagan, Gerry
    Ansari, Zainab
    Stockley, Robert A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (01) : 19 - 26
  • [22] Inhaled Salmeterol/Fluticasone PropionateA Review of its Use in Chronic Obstructive Pulmonary Disease
    Caroline Fenton
    Gillian M. Keating
    Drugs, 2004, 64 : 1975 - 1996
  • [23] Inhaled salmeterol/fluticasone propionate - A review of its use in chronic obstructive pulmonary disease
    Fenton, C
    Keating, GM
    DRUGS, 2004, 64 (17) : 1975 - 1996
  • [24] Salmeterol/Fluticasone propionate - A review of its use in the treatment of chronic obstructive pulmonary disease
    Keating, Gillian M.
    McCormack, Paul L.
    DRUGS, 2007, 67 (16) : 2383 - 2405
  • [25] The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease
    Sin, Don D.
    Man, S. F. Paul
    Marciniuk, Darcy D.
    Ford, Gordon
    FitzGerald, Mark
    Wong, Eric
    Yorks, Ernest
    Mainra, Rajesh R.
    Ramesh, Warren
    Melenka, Lyle S.
    Wilde, Eric
    Cowie, Robert L.
    Williams, Dave
    Gan, Wen Q.
    Rousseau, Roxanne
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (11) : 1207 - 1214
  • [26] Evaluation of salmeterol xinafoate plus fluticasone propionate for the treatment of chronic obstructive pulmonary disease
    Restrepo, Ruben D.
    Tate, Andrew
    Coquat, Joshua
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (14) : 1993 - 2002
  • [27] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
    Calverley, P
    Pauwels, R
    Vestbo, J
    Jones, P
    Pride, N
    Gulsvik, A
    Anderson, J
    Maden, C
    LANCET, 2003, 361 (9356): : 449 - 456
  • [28] Indacaterol/glycopyrronium (IND/GLY) is cost-effective compared with salmeterol/fluticasone (SFC) in Swedish chronic obstructive pulmonary disease (COPD) patients
    Bjermer, Leif
    van Boven, Job F. M.
    Costa-Scharplatz, Madlaina
    Gutzwiller, Florian S.
    Lisspers, Karin
    Mahon, Ronan
    van der Molen, Thys
    Olsson, Petter
    Roche, Nicolas
    Burke, Colin
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [29] ARFORMOTEROL TARTRATE IN THE TREATMENT OF BRONCHOCONSTRICTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Madaan, Arvind
    DRUGS OF TODAY, 2009, 45 (01) : 3 - 9
  • [30] Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial
    Aaron, Shawn D.
    Vandemheen, Katherine L.
    Fergusson, Dean
    Maltais, Francois
    Bourbeau, Jean
    Goldstein, Roger
    Balter, Meyer
    O'Donnell, Denis
    McIvor, Andrew
    Sharma, Sat
    Bishop, Graham
    Anthony, John
    Cowie, Robert
    Field, Stephen
    Hirsch, Andrew
    Hernandez, Paul
    Rivington, Robert
    Road, Jeremy
    Hoffstein, Victor
    Hodder, Richard
    Marciniuk, Darcy
    McCormack, David
    Fox, George
    Cox, Gerard
    Prins, Henry B.
    Ford, Gordon
    Bleskie, Dominique
    Doucette, Steve
    Mayers, Irvin
    Chapman, Kenneth
    Zamel, Noe
    FitzGerald, Mark
    ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) : 545 - U15
12345